Amiodarone (Amio) or a conservatively programmed, shock only implantable cardioverter defibrillator (ICD) v placebo for congestive heart failure at median 46 months*

OutcomeAmioICDPlaceboRRR (95% CI)NNT (CI)
*NS  =  not significant. Other abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article.
All cause mortality9.5%9.7%1.6% (−16 to 17)NS
7.2%9.7%25% (10 to 38)41 (25 to 108)